Literature DB >> 15753192

Topical alpha-tocopherol acetate in the bulk phase: eight years of experience in skin treatment.

Giorgio Panin1, Renata Strumia, Fulvio Ursini.   

Abstract

Clinical practice in dermatology indicates that alpha-tocopherol acetate is beneficial in xerosis, hyperkeratosis, asteatotic eczema, atopic dermatitis, superficial burns, cutaneous ulcers, onychoschizia and, in general, skin diseases in which an inflammatory process is activated. The positive effect results from the combination of biological activity, the absence of adverse reactions, and the physical effect of the alpha-tocopherol acetate oil. The viscosity of this oil in bulk phase accounts for a remarkable moisturizing effect and minimization of transepidermal water loss. This effect combines well with the antioxidant capacity of alpha-tocopherol released from the ester, and the recently emerging effect on reprogramming of gene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15753192     DOI: 10.1196/annals.1331.069

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  [Hyperplastic scars and keloids. Part I: basics and prevention].

Authors:  A Baisch; F Riedel
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

2.  Propagation of cutaneous thermal injury: a mathematical model.

Authors:  Chuan Xue; Ching-Shan Chou; Chiu-Yen Kao; Chandan K Sen; Avner Friedman
Journal:  Wound Repair Regen       Date:  2011-12-30       Impact factor: 3.617

Review 3.  Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death.

Authors:  V E Kagan; Y Y Tyurina; W Y Sun; I I Vlasova; H Dar; V A Tyurin; A A Amoscato; R Mallampalli; P C A van der Wel; R R He; A A Shvedova; D I Gabrilovich; H Bayir
Journal:  Free Radic Biol Med       Date:  2019-12-25       Impact factor: 7.376

4.  Cutaneous Wound Healing after Topical Application of Pistacia atlantica Gel Formulation in Rats.

Authors:  Seyed Ahmadreza Hamidi; Aboutorab Tabatabaei Naeini; Ahmad Oryan; Mohammad Reza Tabandeh; Nader Tanideh; Saeed Nazifi
Journal:  Turk J Pharm Sci       Date:  2017-04-15

5.  Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.

Authors:  Orest Szczurko; Neil Shear; Anna Taddio; Heather Boon
Journal:  BMC Complement Altern Med       Date:  2011-03-15       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.